Navigation Links
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
Date:2/13/2008

change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development (including the successful development of JUVISTA(R) (Human TGFb3)), manufacturing and commercialization (including the launch and establishment in the market of VYVANSE(TM)); the impact of competitive products, including, but not limited to the impact of those on Shire's Attention Deficit and Hyperactivity Disorder ("ADHD") franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine) extended release (ADHD) and GA-GCB (Gene-Activated Glucocerebrosidane); Shire's ability to secure new products for commercialization and/or development; Shire's ability to benefit from its acquisition of New River Pharmaceuticals Inc.; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, particularly Shire plc's Annual Report on Form 10-K for the year ended December 31, 2006.

---------------------------------

(1) Epsicom Business Intelligence. (June 30, 2007) The Pharmaceutical Market: Mexico


'/>"/>
SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
2. Genzyme Receives Approval to Market Elaprase(R) in Japan
3. Clexane(R)/Lovenox(R) Approved in Japan
4. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
5. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
6. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
7. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
8. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
9. Biomoda Announces Collaborative Agreement With New Mexico Tech
10. Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean
11. Prestigious Bioethics Award for Scholar from Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... The report “Adipic Acid Market by Application, ... Trends & Forecast to 2019” report analyzes the ... opportunities, and trends in different regions. , Browse ... through 217 slides and in-depth TOC on “Adipic ... 2019”., http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html , Early buyers will receive ...
(Date:10/25/2014)... ViaDerma, Inc (OTCQB: ... to bringing new products to market, is committed ... has developed an innovative, patent-pending dual carrier transdermal ... of pharmaceutical active ingredients to penetrate the skin ... therapy. The transdermal delivery method also overcomes microbial ...
(Date:10/25/2014)... York, NY (PRWEB) October 23, 2014 ... announced the winners for the 2014 BioProcess International ... business strategies, social corporate responsibility and technology applications ... more effective treatments to a global patient base. ... by their peers during a very entertaining and ...
(Date:10/25/2014)... According to new market research report ... (Colocation, Enterprise, Telecom), by Design Types (Electrical, Mechanical), ... Tier 3, Tier 4) - Global Forecast to ... Data Center Construction Market into various segments with ... research report also identifies the factors driving this ...
Breaking Biology Technology:Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 2Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 3Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 4ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 2Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 4
... ANNAPOLIS, Md. , Jan. 26 The following ... CEO of PharmAthene, regarding the Commission on the Prevention of ... Today,s Report Card by the Commission on the Prevention of ... warning that America still remains vulnerable to bioterrorism.  Our Nation,s ...
... , SHANGHAI , ... pharmaceutical R&D outsourcing Service Company in China , announced,that ... visited Sundia on January 22, 2010 . M.Raffarin, ... Serge,Feneuille and Mr. Erwan Davoux of ...
... , , , , ... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ("3SBio" or "the Company"), ... and marketing,biopharmaceutical products, today announced that it will release financial,results for ... 8:00 PM (Eastern) on, Thursday, February 11, 2010 . , ...
Cached Biology Technology:Former French Prime Minister Jean-Pierre Raffarin Visits Sundia 23SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010 2
(Date:10/25/2014)... Oct.  22, 2014   MedNet Solutions , a ... management systems, is pleased to announce the 2014 ... – to be held in Bloomington, Minnesota ... to have record attendance and promises to be informative, ... The focus of the meeting is iMedNet™ ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 This ... is a relatively new space in heavy pursuit of ... are unique to miRNAs compared to other RNA components. ... make it a novel candidate for use as a ... pursuit of miRNA-based microarrays and diagnostics for the advancement ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 A ... in-depth analysis of the current and future genetic testing ... principles and types are covered in this report. On ... market trends; drivers; and existing strengths and challenges; forecast ... the market is likely to grow at a CAGR ...
Breaking Biology News(10 mins):MedNet Solutions To Host Third Annual iMedNet User Group Meeting 2MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Genetic Testing Market Outlook 2018 2
... pain more than men despite the popular notion that the ... differences in pain have found that not only do women ... also experience it in more bodily areas, more often and ... seem to be differences in how men and women think ...
... base are the guinea pigs for Oak Ridge National ... better determine whether a species has vanished. , After ... biologists were a bit concerned and were looking for ... ecologist and member of ORNL's Environmental Sciences Division. A ...
... a newly released method to analyze functional magnetic ... that the interconnections between different parts of the ... other findings answer longstanding debates about how brain ... are presented in the current (June 1) issue ...
Cached Biology News:Women feel more pain than men, research shows 2Women feel more pain than men, research shows 3Elusive salamanders have role in developing new sampling models 2Elusive salamanders have role in developing new sampling models 3Brain networks change according to cognitive task 2Brain networks change according to cognitive task 3